Dianne M. Ferry - Concepedia

Author

Dianne M. Ferry

University of Auckland

Also Known As

Dianne Ferry, Dianne M Ferry, Dianne M. Ferry, Ferry, Dianne M.

Publications

738

Citations

H-Index

Concepts

All Affiliations

University of Auckland Cancer Society of New Zealand University of Otago

About

Dianne M. Ferry is an author at University of Auckland specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	309
2	Biochemistry	3	3	172
3	Natural Sciences	1	1	16
4	Cell Biology	1	1	82
5	Chemistry	1	1	16

Dianne M. Ferry

Publications

731

Citations

H-Index

Page 1

	Year	Citations
Mechanism of Action and Preclinical Antitumor Activity of the Novel Hypoxia-Activated DNA Cross-Linking Agent PR-104 Adam V. Patterson, Dianne M. Ferry, Shelley J. Edmunds, Clinical Cancer Research	2007	243
DNA Cross-Links in Human Tumor Cells Exposed to the Prodrug PR-104A: Relationships to Hypoxia, Bioreductive Metabolism, and Cytotoxicity Rachelle S. Singleton, Christopher P. Guise, Dianne M. Ferry, Cancer Research Chemoprevention StrategyTumor Growth DelayRedox BiologyTumor BiologyToxicological Mechanism	2009	82
Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis C. H. Hobson, T. J. Butt, Dianne M. Ferry, Gastroenterology InflammationMucosal ImmunologyBacterial Chemotactic PeptidePhysiologyImmunology	1988	80
Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards William R. Wilson, Kevin O. Hicks, Susan M. Pullen, Radiation Research PharmacotherapySevere HypoxiaRedox BiologyTumor BiologyOxidative Stress	2007	74
Synthesis and Evaluation of Nitroheterocyclic Carbamate Prodrugs for Use with Nitroreductase-Mediated Gene-Directed Enzyme Prodrug Therapy Michael P. Hay, Robert F. Anderson, Dianne M. Ferry, Journal of Medicinal Chemistry	2003	66
Bacterial chemotactic oligopeptides and the intestinal mucosal barrier Dianne M. Ferry, T. J. Butt, Murray F. Broom, Gastroenterology Bacterial Chemotactic OligopeptidesMicrobiologyDigestive TractMicrobiomeGut Barrier	1989	57
Cross-Bridged Cyclen or Cyclam Co(III) Complexes Containing Cytotoxic Ligands as Hypoxia-Activated Prodrugs John Yu-Chih Chang, Guo‐Liang Lu, Ralph J. Stevenson, Inorganic Chemistry	2013	44
Hypoxia-Selective Antitumor Agents. 13. Effects of Acridine Substitution on the Hypoxia-Selective Cytotoxicity and Metabolic Reduction of the Bis-bioreductive Agent Nitracrine <i>N</i>-Oxide Ho H. Lee, William R. Wilson, Dianne M. Ferry, Journal of Medicinal Chemistry	1996	37
Aziridinyldinitrobenzamides: Synthesis and Structure−Activity Relationships for Activation by <i>E. </i><i>coli</i> Nitroreductase Nuala A. Helsby, Graham J. Atwell, Shangjin Yang, Journal of Medicinal Chemistry	2004	32
Pathways of Reductive Fragmentation of Heterocyclic Nitroarylmethyl Quaternary Ammonium Prodrugs of Mechlorethamine Angela G. Kriste, Moana Tercel, Robert F. Anderson, Radiation Research Medicinal ChemistryPharmaceutical ChemistryBiochemistryReductive FragmentationMedicine	2002	16

Page 1